introduction: about gdufa
Published 7 years ago • 2.2K plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
8:40
gdufa
-
5:04
gdufa iii: facility readiness
-
11:19
gdufa iii mcrm external training presentation final
-
5:53
gdufa ii training ir and dr letters, michael folkendt
-
2:57:33
a deep dive: gdufa iii scientific meetings
-
6:37
gdufa ii training - performance goals, vince sansone
-
1:06
what does fda do?
-
51:35
update on gdufa science and research
-
1:12:08
advancing generic drug development: translating science to approval 2024 – day 1 – part 2
-
7:38
how does the fda approve a drug?
-
1:52:53
advancing generic drug development: translating science to approval 2024 – day 2 – part 3
-
8:01
gdufa iii: controlled correspondence
-
6:53
gdufa ii training - dmf update, erin skoda
-
15:13
drug master files from a gdufa ii user fee perspective
-
17:19
gdufa ii – review timelines (14of27) generic drugs forum 2018
-
1:21
what does fda regulate?
-
19:43
gdufa ii (9/28) generic drugs forum 2017
-
12:30
an overview of fda's patent listing process
-
16:56
global generic drug landscape
-
5:37
gdufa ii training - pre anda product development meetings, robert lionberger
-
2:26:13
redesigned pre-submission meetings in gdufa iii: benefits for anda submission and approval
-
5:00
who is the u.s. food and drug administration fda